{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:51:59Z","timestamp":1790999519703,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T00:00:00Z","timestamp":1474675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Israel Institute for Biological Research","award":["SB-241"],"award-info":[{"award-number":["SB-241"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum neurotoxins are bacterial proteins that cause botulism, a life-threatening disease. Therapy relies mostly on post-intoxication antibody treatment. The only accepted method to measure the potency of, and to approve, antitoxin preparations is the mouse lethality neutralization bioassay. However, this assay is time-consuming, labor-intensive, costly, and raises ethical issues related to the large numbers of laboratory animals needed. Until now, all efforts to develop an alternative in vitro assay have not provided a valid replacement to the mouse potency assay. In the present study, we report the development of an innovative in vitro assay for determining botulinum antitoxin potency, using botulinum type B as a model. The concept of the assay is to mimic two fundamental steps in botulinum intoxication: receptor binding and catalytic activity. By simulating these steps in vitro we were able to accurately determine the potency of antitoxin preparations. The reproducibility of the assay was high with a CV &lt; 13%. Most importantly, the antitoxin potency measured by the in vitro assay highly correlated with that measured by the standard in vivo mouse assay (r = 0.9842, p &lt; 0.0001). Thus, this new in vitro assay has the potential to be considered, after validation, as a replacement to the mouse assay for quantitating neutralizing antibody concentrations in pharmaceutical botulinum antitoxin preparations. Future adoption of this in vitro assay would minimize the use of laboratory animals, speed up the time, and reduce the cost of botulinum antitoxin approval.<\/jats:p>","DOI":"10.3390\/toxins8100276","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T10:02:44Z","timestamp":1474884164000},"page":"276","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-1755","authenticated-orcid":false,"given":"Osnat","family":"Rosen","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona 7410001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Ozeri","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona 7410001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Barnea","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona 7410001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"David","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona 7410001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zichel","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Israel Institute for Biological Research, Ness Ziona 7410001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Balows, A., Hausler, W.J., Ohashi, M., Turano, A., and Lennete, E.H. (1988). Laboratory Diagnosis of Infectious Diseases, Springer.","DOI":"10.1007\/978-1-4612-3898-0"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: Structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","unstructured":"Centers for Disease Control and Prevention (CDC) CSTE botulism surveillance summary 2014, Available online: https:\/\/www.cdc.gov\/nationalsurveillance\/pdfs\/botulism_cste_2014.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: Medical and public health managment","volume":"285","author":"Arnon","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type a foodborne botulism","volume":"76","author":"Tacket","year":"1984","journal-title":"Am. J. Med."},{"key":"ref_10","unstructured":"European Directorate for the Quality of Medicines and Healthcare (2014). European Pharmacopoeia, EDQM Council of Europe. [8th ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000052139","article-title":"Botulinum toxin antibody testing: Comparison between the immunoprecipitation assay and the mouse diaphragm assay","volume":"45","author":"Dressler","year":"2001","journal-title":"Eur Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/WNL.50.6.1624","article-title":"Mouse bioassay versus western blot assay for botulinum toxin antibodies: Correlation with clinical response","volume":"50","author":"Hanna","year":"1998","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1045-1056(02)00074-X","article-title":"Evaluation of a botulinum fragment C-based elisa for measuring the humoral immune response in primates","volume":"31","author":"Lindsey","year":"2003","journal-title":"Biologicals"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.50.5.1463","article-title":"A radioimmuno-precipitation assay for antibodies to botulinum A","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.febslet.2007.08.078","article-title":"A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies","volume":"581","author":"Pellett","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.bios.2010.06.035","article-title":"Synaptotagmin II peptide-bead conjugate for botulinum toxin enrichment and detection in microchannels","volume":"26","author":"Frisk","year":"2010","journal-title":"Biosens. Bioelectron."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1128\/AEM.65.9.3787-3792.1999","article-title":"Development of an in vitro bioassay for clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay","volume":"65","author":"Wictome","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ab.2006.01.027","article-title":"The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples","volume":"351","author":"Kalb","year":"2006","journal-title":"Anal. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2008.05.009","article-title":"An improved method for development of toxoid vaccines and antitoxins","volume":"337","author":"Jones","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/jcm.34.8.1934-1938.1996","article-title":"Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities","volume":"34","author":"Hallis","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1093\/cid\/civ861","article-title":"Early, real-time medical diagnosis of botulism by endopeptidase-mass spectrometry","volume":"61","author":"Rosen","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/ac050485f","article-title":"From the mouse to the mass spectrometer: Detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry","volume":"77","author":"Boyer","year":"2005","journal-title":"Anal. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1021\/ac0511748","article-title":"Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics","volume":"77","author":"Kalb","year":"2005","journal-title":"Anal. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ab.2011.01.025","article-title":"Improved detection of botulinum neurotoxin type A in stool by mass spectrometry","volume":"412","author":"Wang","year":"2011","journal-title":"Anal. Biochem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1007\/s00216-014-8170-4","article-title":"Validation of the Endopep\u2013MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum","volume":"406","author":"Bjornstad","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1021\/jf505482b","article-title":"Detection of botulinum toxins A, B, E, and F in foods by Endopep-MS","volume":"63","author":"Kalb","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05411","article-title":"Structural basis of cell surface receptor recognition by botulinum neurotoxin B","volume":"444","author":"Chai","year":"2006","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity","volume":"444","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3201\/eid1110.041279","article-title":"Botulinum neurotoxin detection and differentiation by mass spectrometry","volume":"11","author":"Barr","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_30","first-page":"701","article-title":"Preparation and assay of the international standards for clostridium botulinum types A, B, C, D and E antitoxins","volume":"29","author":"Bowmer","year":"1963","journal-title":"Bull. World Health Organ."},{"key":"ref_31","unstructured":"Food and Drug Administration (FDA) Highlights of prescribing information, Available online: http:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-bio-gen\/documents\/document\/ucm345147.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/150.3.407","article-title":"Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E","volume":"150","author":"Hatheway","year":"1984","journal-title":"J. Infect. Dis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2010.11.128","article-title":"Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells","volume":"404","author":"Pellett","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vascn.2010.01.003","article-title":"Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination","volume":"61","author":"Pellett","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/1087057106299163","article-title":"Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: Implications for therapeutic discovery","volume":"12","author":"Stahl","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.048","article-title":"Dominant antigenic peptides located at the heavy chain terminal of botulinum neurotoxin B contain receptor-binding sites for synaptotagmin II","volume":"374","author":"Shi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","article-title":"Human synaptotagmin-ii is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity","volume":"586","author":"Strotmeier","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/aem.58.8.2345-2354.1992","article-title":"Molecular cloning of the clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence","volume":"58","author":"Whelan","year":"1992","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/CVI.00496-09","article-title":"Efficacy of a potential trivalent vaccine based on hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system","volume":"17","author":"Zichel","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_40","unstructured":"European Directorate for the Quality of Medicines and Healthcare (2011). European Pharmacopoeia, EDQM Council of Europe. [7th ed.]."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2014.03.024","article-title":"Improved detection of botulinum type E by rational design of a new peptide substrate for endopeptidase-mass spectrometry assay","volume":"456","author":"Rosen","year":"2014","journal-title":"Anal. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ab.2014.09.016","article-title":"A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry\/multiple reaction monitoring assay","volume":"473","author":"Rosen","year":"2015","journal-title":"Anal. Biochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1021\/ac502948v","article-title":"A two-stage multiplex method for quantitative analysis of botulinum neurotoxins type A, B, E, and F by MALDI-TOF mass spectrometry","volume":"86","author":"Wang","year":"2014","journal-title":"Anal. Chem."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/10\/276\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:31:42Z","timestamp":1760211102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/8\/10\/276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,24]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"alternative-id":["toxins8100276"],"URL":"https:\/\/doi.org\/10.3390\/toxins8100276","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,24]]}}}